These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 36536233)

  • 1. Putative Animal Models of Restless Legs Syndrome: A Systematic Review and Evaluation of Their Face and Construct Validity.
    Silvani A; Ghorayeb I; Manconi M; Li Y; Clemens S
    Neurotherapeutics; 2023 Jan; 20(1):154-178. PubMed ID: 36536233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D3 Receptors and Restless Legs Syndrome.
    Clemens S
    Curr Top Behav Neurosci; 2023; 60():229-249. PubMed ID: 35435646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restless legs syndrome - a review].
    Sveinsson OA; Sigurdsson AP
    Laeknabladid; 2012 Jan; 98(1):33-7. PubMed ID: 22253081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restless legs syndrome: differential diagnosis and management with pramipexole.
    Brindani F; Vitetta F; Gemignani F
    Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D3 receptor agonist efficacy in restless legs syndrome.
    Casoni F; Galbiati A; Ferini-Strambi L
    Adv Pharmacol; 2019; 84():21-35. PubMed ID: 31229173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron for the treatment of restless legs syndrome.
    Trotti LM; Becker LA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome: a review.
    Chahine LM; Chemali ZN
    CNS Spectr; 2006 Jul; 11(7):511-20. PubMed ID: 16816791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole for the treatment of restless legs syndrome.
    Kushida CA
    Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Treatment of Restless Legs Syndrome.
    Lv Q; Wang X; Asakawa T; Wang XP
    Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.
    Earley CJ; Uhl GR; Clemens S; Ferré S
    Sleep Med; 2017 Mar; 31():71-77. PubMed ID: 27539027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.
    Littner MR; Kushida C; Anderson WM; Bailey D; Berry RB; Hirshkowitz M; Kapen S; Kramer M; Lee-Chiong T; Li KK; Loube DL; Morgenthaler T; Wise M;
    Sleep; 2004 May; 27(3):557-9. PubMed ID: 15164914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restless legs syndrome.
    Manconi M; Garcia-Borreguero D; Schormair B; Videnovic A; Berger K; Ferri R; Dauvilliers Y
    Nat Rev Dis Primers; 2021 Nov; 7(1):80. PubMed ID: 34732752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.